Glomerulonephritis Clinical Trials Glomerulonephritis RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Trial to Evaluate the Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) (NewPLACE)
Conditions:   Glomerulonephritis;   Membranous Nephropathy;   antiPLA2R Positive Intervention:   Drug: MOR202 Sponsor:   MorphoSys AG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2021 Category: Research Source Type: clinical trials